Skip to main content
. Author manuscript; available in PMC: 2013 Jul 16.
Published in final edited form as: Biopharm Drug Dispos. 2009 Jan;30(1):21–34. doi: 10.1002/bdd.643

Figure 2.

Figure 2

Pharmacokinetics of MPL upon administration of 10 (●) and 50 (○) mg/kg intravenous injection (top), or 0.1 (●) and 0.3 (○) mg/kg/h subcutaneous infusion for 7 days (bottom). Symbols are observed drug concentrations. Lines in top graph are results of simulation using established parameters. Lines in bottom graph are results of the simultaneous fitting with Equations (13). The PK parameters are listed in Table 1.